polarix study: frontline therapy in dlbcl
Published 2 years ago • 875 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
3:12
polarix: polatuzumab vedotin and r-chp superior to r-chop in dlbcl
-
4:27
polarix: how does myc and bcl2 expression impact outcomes post frontline treatment with pv in dlbcl?
-
2:03
novel treatment approaches for early-stage dlbcl
-
21:26
polatuzumab fda approval in dlbcl (polarix) & swog s1826 nivo vs. bv in hodgkin's lymphoma
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
3:04
applying molecular understanding of dlbcl to management strategies
-
4:47
the polarix trial: initial therapy of diffuse large b-cell lymphoma
-
55:33
polarix lymphoma trial debate
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
0:42
targeted therapies for dlbcl treatment
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:46
ivlbcl: a retrospective study
-
0:48
an introduction to the maxilus study: the optimal dose of luspatercept in lr-mds
-
0:41
isct in bringing together the scientific community
-
1:55
update on the phase i/ii bruin study
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl
-
3:40
master class in transplantation and hematology: highlights